Going Global. Khosla-AliveCor. Propeller Strategy.

In this article:

The first edition of the E&O Weekly newsletter for paying subscribers. Topics included: Going Global. Khosla-AliveCor. Propeller Strategy.

Issue 001. Going Global. Khosla-AliveCor. Propeller Strategy.

Get E&O weekly. | Subscribe
Digital health research from Brian Dolan.

Welcome to E&O.

** Wow. What a week. Thanks for the support. And, hey, if you aren't already a paying subscriber and this was forwarded your way, sign up right over here.

This is Issue 001: Let's get to it already.

Khosla owned AliveCor: This week I learned Khosla Ventures held a majority stake in AliveCor a few years back, but is now just the largest shareholder. Was that an open secret? How many other digital health companies (were at one time or) are currently mostly owned by a single investor?

Livongo S-1 research follow-up: E&O's first report focused on Glen Tullman's soon-to-IPO-company, Livongo. Readers have pointed out a few things in reaction to it: 1). Livongo seems to have sat on its acquisition of Diabeto, which could have enabled Livongo to

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Going Global. Khosla-AliveCor. Propeller Strategy.

Welcome to E&O.

This is Issue 001: Let's get to it already.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.